ritalin la 10 mg modified-release capsules
novartis israel ltd - methylphenidate hydrochloride - modified release capsules - methylphenidate hydrochloride 10 mg - methylphenidate - attention deficit hyperactivity disorder (adhd) .
ritalin la 20 mg modified-release capsules
novartis israel ltd - methylphenidate hydrochloride - modified release capsules - methylphenidate hydrochloride 20 mg - methylphenidate - attention deficit hyperactivity disorder (adhd).
ritalin la 30 mg modified-release capsules
novartis israel ltd - methylphenidate hydrochloride - modified release capsules - methylphenidate hydrochloride 30 mg - methylphenidate - attention deficit hyperactivity disorder (adhd).
ritalin la 40 mg modified-release capsules
novartis israel ltd - methylphenidate hydrochloride - modified release capsules - methylphenidate hydrochloride 40 mg - methylphenidate - attention deficit hyperactivity disorder (adhd).
sprycel 100 mg
bristol, myers squibb (israel) limited, israel - dasatinib - film coated tablets - dasatinib 100 mg - dasatinib - treatment of adult patients with : * newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. * chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib mesilate. * ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy.
sprycel 20 mg
bristol, myers squibb (israel) limited, israel - dasatinib - film coated tablets - dasatinib 20 mg - dasatinib - treatment of adult patients with : * newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. * chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib mesilate. * ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy.
sprycel 50 mg
bristol, myers squibb (israel) limited, israel - dasatinib - film coated tablets - dasatinib 50 mg - dasatinib - treatment of adult patients with : * newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. * chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib mesilate. * ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy.
sprycel 70 mg
bristol, myers squibb (israel) limited, israel - dasatinib - film coated tablets - dasatinib 70 mg - dasatinib - treatment of adult patients with : * newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. * chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib mesilate. * ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy.
avilac syrup
padagis israel pharmaceuticals ltd, israel - lactulose - syrup - lactulose 66.7 g / 100 ml - lactulose - lactulose - constipation. acute and chronic hepatic encephalopathy.
acrose 50
rafa laboratories ltd - acarbose - tablets - acarbose 50 mg - acarbose - acarbose - treatment of non-insulin dependent diabetes mellitus (niddm) in patients inadequately controlled on diet alone, or on diet and oral hypoglycaemic agents.